Product Center
-
World Influenza Conference 2024 | Decoding new possibilities for the future of influenza vaccines
2024-07-09From July 5 to 7, the 2024 World Influenza Conference, co-sponsored by the Chinese Preventive Medicine Association, the Asia-Pacific Influenza Control Alliance, the Chinese Center for Disease Control and Prevention, and the Chinese Academy of Medical Sciences, was held in Hainan.
Read More -
2024 National Vaccine and Health Conference
2024-04-22On April 20-21, the 2024 National Vaccine Conference and Health Conference was held in Xiongan New Area, Hebei Province. Ab&B Bio brought its first product, the quadrivalent influenza virus subunit vaccine (Huierkangxin HRK-X®) to the event again.
Read More -
Further advances in orthopoxvirus mRNA vaccines
2024-04-12From April 2 to April 4, 2024, Dr. Xiong Nolin, Deputy General Manager of Yither biotech(Shanghai) Co., Ltd, a wholly-owned subsidiary of Ab&B Bio-Tech CO.,LTD.JS, was invited to participate in the World Vaccine Congress 2024, where he made a keynote speech and exchanged the results of the company's important R & D project of the Orthopoxvirus mRNA vaccine, which was received by the international counterparts with great interest and recognition.
Read More -
Zhang Xiaobing, member of the Standing Committee of the Taizhou Municipal Party Committee and Secretary of the Party Working Committee of the Pharmaceutical High-tech Zone, visited the company for investigation
2019-01-14Zhang Xiaobing, member of the Standing Committee of the Taizhou Municipal Party Committee and Secretary of the Party Working Committee of the Pharmaceutical High-tech Zone, visited the company for inv
Read More
Have a project？Get a touch!
Caring for life, protecting health, and making global technological innovation vaccines are the mission of Ab&B Bio
Contact
E-mail:info@abbbio.com.cn
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City
Quick view
Follow us
